UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~November~~May 29, ~~2024~~2025

Elite Health Systems Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-26575	52-1842411
(State of other jurisdiction of	(Commission	(I.R.S. Employer
(State of other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification No.)
incorporation or organization)	File Number)	Identification No.)
1131 W 6th Street Ontario, CA		91762
(Address of principal executive offices)		(Zip Code)

1131 W 6th Street
Ontario, CA		91672
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code:

(949) 249-1170

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry onto a Material Agreement.

AsOn ~~previously~~May ~~reported~~29, on2025, ~~January~~Elite ~~16,~~Health ~~2024~~Plan, Inc. (“Elite Health ~~Systems~~Plan”) ~~Inc,~~a ~~formerly~~wholly ~~U.S.~~owned ~~NeuroSurgical~~subsidiary ~~Holdings,~~of ~~Inc.,~~Elite aHealth ~~Delaware~~Systems ~~corporation,~~Inc. (the “~~Company~~Registrant”) ~~held~~was anawarded ~~initial~~a ~~closing~~license ofas a ~~private~~full-service ~~placement~~health ofcare ~~shares~~service plan pursuant to the provisions of the ~~Company’s~~Knox-Keene ~~common~~Health ~~stock~~Care atService aPlan ~~price~~Act of ~~$0.50~~1976 ~~per~~(the ~~share~~“Act”), as amended. ToSubect ~~date,~~to the ~~Company~~required ~~has~~approvals ~~raised~~from anthe ~~aggregate~~Centers offor ~~approximately~~Medicare ~~$5.05~~& ~~million.~~Medicaid ~~Effective~~Services ~~November 29~~(“CMS”), ~~2024,~~this license authorizes Elite Health Plan to engage in business as a health care service plan within the ~~Board~~state of ~~Directors~~California subject to the provisions of the ~~Company~~Act, (the ~~“Board”)~~rules ~~approved~~promulgated ~~amending~~pursuant to the ~~terms~~Act, and the orders of the ~~private~~director, ~~placement~~until such time as the license is suspended or revoked. Elite Health Plan expects to ~~raise~~file upits calendar year 2026 bid submission to $5CMS within the next few days. The regulatory process is complex and there can be no assurance that CMS will approve its bid or that,~~500~~ if approved,~~000~~ ~~maximum~~that Elite Health Plan is able to maintain its license under the Act or its approval from CMS.

Item 8.01. Other Events

Effective November 29, 2024, the Board approved the issuance of an aggregate of 480,000 shares of its Common Stock to certain individuals, including directors and officers of the Company, in lieu of cash compensation for services rendered and to be rendered through the 2024 fiscal year.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 2, 2024
Date: May 30, 2025
	Elite Health Systems Inc.
	By:	/s/ Prasad Jeereddi
	Name:	Prasad Jeereddi
	Title:	Chairman and CEO

Filing Compare · Elite Health Systems Inc.